Shanghai, China · Founded 2017 · Privately Held (backing)
Developer of nuclear receptor drugs intended to provide new therapies for chronic liver diseases. Cascade Pharma is based in Shanghai, China and was founded in 2017. It has raised $218 million.
Last price · $/share
—
Implied valuation
—
Total raised
$217.6M
Last round
—
Cap table — not yet on record
Cascade Pharma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Cascade Pharma with a free account
·The complete investor list: 24 names
·Watch Cascade Pharma: the Monday email on marks, rounds and moves
